Search research articles
Contact Us
Filters
Showing results (51-60 of 94) with videos related to
Page
of 10
Sort By:
Bioconjugate Chemistry
|
September 10, 2009
A new method to produce monoPEGylated dimeric cytokines shown with human interferon-α2b
Chien-Hsing Chang, Edmund A Rossi, Thomas M Cardillo, et al.
Cancer Research
|
July 3, 2008
Improved therapeutic results by pretargeted radioimmunotherapy of non-Hodgkin's lymphoma with a new recombinant, trivalent, anti-CD20, bispecific antibody
Robert M Sharkey, Habibe Karacay, Samuel Litwin, et al.
Molecular Cancer Therapeutics
|
November 15, 2017
IMMU-140, a Novel SN-38 Antibody-Drug Conjugate Targeting HLA-DR, Mediates Dual Cytotoxic Effects in Hematologic Cancers and Malignant Melanoma
Thomas M Cardillo, Serengulam V Govindan, Maria B Zalath, et al.
Bioconjugate Chemistry
|
June 15, 2010
Improved 18F labeling of peptides with a fluoride-aluminum-chelate complex
William J McBride, Christopher A D'Souza, Robert M Sharkey, et al.
Blood
|
January 27, 2010
Therapy of B-cell malignancies by anti-HLA-DR humanized monoclonal antibody, IMMU-114, is mediated through hyperactivation of ERK and JNK MAP kinase signaling pathways
Rhona Stein, Pankaj Gupta, Xiaochuan Chen, et al.
Oncotarget
|
February 22, 2024
Sacituzumab govitecan plus platinum-based chemotherapy mediates significant antitumor effects in triple-negative breast, urinary bladder, and small-cell lung carcinomas
Thomas M Cardillo, Maria B Zalath, Roberto Arrojo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2007
CD74: a new candidate target for the immunotherapy of B-cell neoplasms
Rhona Stein, M Jules Mattes, Thomas M Cardillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2003
Development of new multivalent-bispecific agents for pretargeting tumor localization and therapy
Edmund A Rossi, Robert M Sharkey, William McBride, et al.
Cancer Research
|
August 19, 2017
Combination Therapy with Bispecific Antibodies and PD-1 Blockade Enhances the Antitumor Potency of T Cells
Chien-Hsing Chang, Yang Wang, Rongxiu Li, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 19, 2009
Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphoma
Robert M Sharkey, Habibe Karacay, Christine R Johnson, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 94) with videos related to
Sort By:
Page
of 10
Bioconjugate Chemistry
|
September 10, 2009
A new method to produce monoPEGylated dimeric cytokines shown with human interferon-α2b
Chien-Hsing Chang, Edmund A Rossi, Thomas M Cardillo, et al.
Cancer Research
|
July 3, 2008
Improved therapeutic results by pretargeted radioimmunotherapy of non-Hodgkin's lymphoma with a new recombinant, trivalent, anti-CD20, bispecific antibody
Robert M Sharkey, Habibe Karacay, Samuel Litwin, et al.
Molecular Cancer Therapeutics
|
November 15, 2017
IMMU-140, a Novel SN-38 Antibody-Drug Conjugate Targeting HLA-DR, Mediates Dual Cytotoxic Effects in Hematologic Cancers and Malignant Melanoma
Thomas M Cardillo, Serengulam V Govindan, Maria B Zalath, et al.
Bioconjugate Chemistry
|
June 15, 2010
Improved 18F labeling of peptides with a fluoride-aluminum-chelate complex
William J McBride, Christopher A D'Souza, Robert M Sharkey, et al.
Blood
|
January 27, 2010
Therapy of B-cell malignancies by anti-HLA-DR humanized monoclonal antibody, IMMU-114, is mediated through hyperactivation of ERK and JNK MAP kinase signaling pathways
Rhona Stein, Pankaj Gupta, Xiaochuan Chen, et al.
Oncotarget
|
February 22, 2024
Sacituzumab govitecan plus platinum-based chemotherapy mediates significant antitumor effects in triple-negative breast, urinary bladder, and small-cell lung carcinomas
Thomas M Cardillo, Maria B Zalath, Roberto Arrojo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2007
CD74: a new candidate target for the immunotherapy of B-cell neoplasms
Rhona Stein, M Jules Mattes, Thomas M Cardillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 2003
Development of new multivalent-bispecific agents for pretargeting tumor localization and therapy
Edmund A Rossi, Robert M Sharkey, William McBride, et al.
Cancer Research
|
August 19, 2017
Combination Therapy with Bispecific Antibodies and PD-1 Blockade Enhances the Antitumor Potency of T Cells
Chien-Hsing Chang, Yang Wang, Rongxiu Li, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 19, 2009
Pretargeted versus directly targeted radioimmunotherapy combined with anti-CD20 antibody consolidation therapy of non-Hodgkin lymphoma
Robert M Sharkey, Habibe Karacay, Christine R Johnson, et al.
Page
of 10